Inspire Medical Systems Gross Margin 2017-2023 | INSP
Current and historical gross margin for Inspire Medical Systems (INSP) over the last 10 years. The current gross profit margin for Inspire Medical Systems as of December 31, 2023 is %.
| Inspire Medical Systems Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $0.63B | $0.53B | 84.48% |
| 2023-09-30 | $0.57B | $0.48B | 84.21% |
| 2023-06-30 | $0.53B | $0.44B | 83.65% |
| 2023-03-31 | $0.47B | $0.39B | 83.69% |
| 2022-12-31 | $0.41B | $0.34B | 83.78% |
| 2022-09-30 | $0.35B | $0.29B | 84.15% |
| 2022-06-30 | $0.30B | $0.26B | 85.33% |
| 2022-03-31 | $0.26B | $0.22B | 85.50% |
| 2021-12-31 | $0.23B | $0.20B | 85.41% |
| 2021-09-30 | $0.20B | $0.17B | 85.07% |
| 2021-06-30 | $0.18B | $0.15B | 85.14% |
| 2021-03-31 | $0.13B | $0.11B | 85.07% |
| 2020-12-31 | $0.12B | $0.10B | 85.22% |
| 2020-09-30 | $0.10B | $0.08B | 85.42% |
| 2020-06-30 | $0.08B | $0.07B | 83.95% |
| 2020-03-31 | $0.09B | $0.07B | 83.91% |
| 2019-12-31 | $0.08B | $0.07B | 82.93% |
| 2019-09-30 | $0.07B | $0.06B | 80.56% |
| 2019-06-30 | $0.06B | $0.05B | 81.25% |
| 2019-03-31 | $0.06B | $0.05B | 80.70% |
| 2018-12-31 | $0.05B | $0.04B | 80.39% |
| 2018-09-30 | $0.04B | $0.04B | 81.82% |
| 2018-06-30 | $0.04B | $0.03B | 81.58% |
| 2018-03-31 | $0.03B | $0.03B | 81.82% |
| 2017-12-31 | $0.03B | $0.02B | 82.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $7.021B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.372B | 21.90 |
| 10x Genomics (TXG) | United States | $4.117B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.520B | 0.00 |
| Axonics (AXNX) | United States | $3.448B | 0.00 |
| Enovis (ENOV) | United States | $3.211B | 24.40 |
| Azenta (AZTA) | United States | $3.053B | 248.86 |
| Hims & Hers Health (HIMS) | United States | $2.991B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.838B | 0.00 |
| Privia Health (PRVA) | United States | $2.200B | 97.58 |
| Schrodinger (SDGR) | United States | $1.913B | 0.00 |
| Phreesia (PHR) | United States | $1.330B | 0.00 |
| Omnicell (OMCL) | United States | $1.248B | 30.54 |
| Definitive Healthcare (DH) | United States | $0.866B | 0.00 |
| Standard BioTools (LAB) | United States | $0.809B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.621B | 0.00 |
| Talkspace (TALK) | United States | $0.588B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.357B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
| Pulmonx (LUNG) | United States | $0.304B | 0.00 |
| Augmedix (AUGX) | United States | $0.186B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.185B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.185B | 0.00 |
| American Well (AMWL) | United States | $0.166B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.158B | 0.00 |
| TruBridge (TBRG) | United States | $0.129B | 5.49 |
| Outset Medical (OM) | United States | $0.106B | 0.00 |
| 111 (YI) | China | $0.092B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| Zepp Health (ZEPP) | China | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.036B | 0.00 |
| Movano (MOVE) | United States | $0.029B | 0.00 |
| Cue Health (HLTH) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Akili (AKLI) | United States | $0.021B | 0.00 |
| ETAO (ETAO) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| Centogene (CNTG) | Germany | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Motus GI Holdings (MOTS) | United States | $0.001B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |